ATE230735T1 - Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken - Google Patents

Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken

Info

Publication number
ATE230735T1
ATE230735T1 AT98936335T AT98936335T ATE230735T1 AT E230735 T1 ATE230735 T1 AT E230735T1 AT 98936335 T AT98936335 T AT 98936335T AT 98936335 T AT98936335 T AT 98936335T AT E230735 T1 ATE230735 T1 AT E230735T1
Authority
AT
Austria
Prior art keywords
pct
naphthothiazolone
derivatives
action
date dec
Prior art date
Application number
AT98936335T
Other languages
English (en)
Inventor
Felice Pocchiari
Claudio Masotto
Paolo Cavalleri
Stefania Montanari
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE230735T1 publication Critical patent/ATE230735T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT98936335T 1997-06-13 1998-06-12 Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken ATE230735T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001398A IT1292155B1 (it) 1997-06-13 1997-06-13 Derivati naftotiazolonici attivi sul recettore dopaminergico d 3
PCT/EP1998/003560 WO1998056778A1 (en) 1997-06-13 1998-06-12 Naphthothiazolone derivatives active on the d3 dopaminergic receptor

Publications (1)

Publication Number Publication Date
ATE230735T1 true ATE230735T1 (de) 2003-01-15

Family

ID=11377358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936335T ATE230735T1 (de) 1997-06-13 1998-06-12 Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken

Country Status (7)

Country Link
US (1) US6107318A (de)
EP (1) EP0988296B1 (de)
AT (1) ATE230735T1 (de)
DE (1) DE69810622T2 (de)
ES (1) ES2189211T3 (de)
IT (1) IT1292155B1 (de)
WO (1) WO1998056778A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10359528A1 (de) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639770A (en) * 1992-05-29 1997-06-17 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives
EP0690843B1 (de) * 1993-03-25 2000-08-30 PHARMACIA & UPJOHN COMPANY Formyl- oder Cyano- substituierte Indolderivate mit dopaminergischer Wirkung

Also Published As

Publication number Publication date
DE69810622D1 (de) 2003-02-13
EP0988296B1 (de) 2003-01-08
US6107318A (en) 2000-08-22
DE69810622T2 (de) 2003-10-30
ES2189211T3 (es) 2003-07-01
IT1292155B1 (it) 1999-01-25
EP0988296A1 (de) 2000-03-29
ITMI971398A1 (it) 1998-12-13
WO1998056778A1 (en) 1998-12-17
ITMI971398A0 (de) 1997-06-13

Similar Documents

Publication Publication Date Title
TW347387B (en) Piperidine derivatives
DK0865281T3 (da) Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
TR199801734T2 (xx) Yeni arilglisinamid t�revleri, �retim y�ntemleri.
MY140749A (en) Novel piperidine compound
ATE230735T1 (de) Naphthothiazolon-derivate die auf den dopaminergen rezeptor d 3 wirken
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
ATE219481T1 (de) 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
NO972938D0 (no) Farmasöytiske piperazinforbindelser
PT925295E (pt) Derivados de n-benzenosulfonil-1-prolina como agonistas da bradiquinina b2
NO970806D0 (no) Dihydropyridin-derivater som bradykinin-antagonister
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
MX207081B (de)
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
NO994104D0 (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
MY124404A (en) Acridin derivatives
ES2060401T3 (es) Nuevos derivados de estroptograminas y su preparacion.
PT1140919E (pt) Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao
IL126548A0 (en) Use of aspirochlorine or derivatives thereof as immunosuppressive agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties